Global Biological Implants Market by Product (Xenografts, Autografts, Allografts), by Application (Cardiovascular Orthopedic, Dental & Dermal Implants) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

The growth in composite grafting and rising advances in tissue engineering are driving the market for biological implants.

Global biological implants market valued at USD 5,070.8 millions in 2015. It is projected to grow 7.6% during the forecast period. The market for biological implants will see significant demand and growth due to technological advances in the fields of , regenerative medicine and tissue Engineering.

Biomaterials that can be used to reconstruct damaged or broken bones will significantly increase revenue generation and accelerate progress to 2024.

For more predictable and aesthetic outcomes, significant improvements have been made to implant surgery procedures. These advances and developments in tissue and implant regeneration all contribute to the growth of these products.

North America Biological Implants Market by Product, 2013 - 2024, USD Million

Companies are also playing an important role in the solution of foreign body rejection that synthetic devices can cause by developing biologically derived reconstructive options. Companies will continue to develop novel products globally. This will encourage them to optimize their portfolios in this area, which will ultimately impact revenue generation.

The regenerative medicine industry, which encompasses a range of therapeutic approaches including the use of bio-based materials or biologics to target the root cause of an illness, has seen a new trend that will drive market growth. They are preferred over prosthetic mesh because they have lower contamination rates and stable vascularization at infected sites.

Promised progress will be impeded by high manufacturing costs and slow uptake because of adverse events.

"Xenografts accounted the largest portion of the product segment for 2015"

2015 saw the greatest share of xenografts due to advances in vascular engineering and tissue engineering. Revenue generation is expected to be significantly affected by the availability and ease of procuring xenogeneic transplants without concern for donor site morbidity.

The fastest growing segment in the future is expected to be allografts. This segment is expected to see a rise in demand and sales due to the exceptional aesthetic results they provide.

"Rising rates of cardiovascular disorders are expected propel the segment growth in cardiovascular implants"

These products can be used for orthopedic, cardiovascular, or other soft tissue implant applications. Because of the wide variety of products in this category, soft tissue implants accounted for the majority of the over 44% share.

Although cardiac implants were not widely used in 2015, they are expected to grow rapidly in the future. This segment is expected to grow in future years due to rising incidence of cardiovascular disorders and cholesterol abnormalities. This segment's projected growth is due to the availability of cardiac tissues such as allograft and heterograft valves. A stentless valve can also be purchased that can be cut according to your requirements.

"Surgical biologic implants are the most popular route of administration"

In 2015, surgical biological implants led the way in revenue share. They are expected to continue their dominance through the forecast period. This is due to the continuous unveiling of new biological products by companies that can be surgically implanted into the body.

In Situ injectable products have emerged as a popular platform for delivering peptides and protein macromolecules. Their ease of use and tissue biocompatibility make them attractive to injectable implant companies. Injectable implantation is becoming more popular due to customer expectations. This has led to a demand for minimally invasive reconstructive surgery in this market.

"North America has the highest revenue share for 2015"

North America held the largest share at over 50% in 2015 This is due to the simultaneous development and use of implants for surgical procedures on extremities. This market is expected to grow due to the high demand from North America for the services offered by this market.

The Asia Pacific region is expected see lucrative growth from 2024 to 2024 due to the growing healthcare infrastructure and systems in China and Japan, as well as favorable government initiatives and the unmet medical needs of patients. In the near future, lucrative growth is expected due to the increased supply of biologic implant products from international companies like Integra Lifesciences or NuVasive and the improvement of the healthcare infrastructure in Latin America and Asia Pacific.

"Market poised for continued growth due to mergers and acquisitions"

The market is dominated by the following key players: Integra LifeSciences Corporation, NuVasive, Inc, Edwards LifeSciences Corporation, Stryker Corporation, Acelity, Medtronic, RTI Surgical, BioPolymer GmbH & co. KG, Baxter International, Vericel, Aplhatec Spine Inc, CryoLife, Maxigen Biotech Inc, IOP Ophthalmics, Conmed Corporation Allergan Plc, Biotissue Technologies, Auto Tissue Berlin GmbH, MiMedx Group, Organogenesis Inc., Osiris Therapeuticsiris Therapeutics Inc, Osiris Therapeuticsis Therapeuticsiris Therapeuticsiris Therapeutics, Osiris Therapeuticsiris Therapeutics Inc, Osiris Therapeuticsis Therapeutics, Osiris Therapeuticsiris Therapeuticsiris Therapeutics Inc, Osiris Therapeutics, Osiris Therapeutics, Edwards LifeSciencesive, Edwards LifeSciencesive, Edwards LifeSciencesive, Os, Osive, Os, Os, Os, Osiris Therapeutics, Osiris Therapeutics They are also involved in the execution of portfolio separations as well as regional expansion strategies to enhance market presence.

Integra LifeSciences Corporation, for example, launched Integra reinforcement matrix in January 2015. This is a bioimplant that can be used to treat tendon injuries. This FDA-approved product is made of porcine dermis. It provides durable reinforcement during tendon repair procedures.

Up Market Research published a new report titled “Biological Implants Market research report which is segmented by Product (Xenografts, Autografts, Allografts), by Application (Cardiovascular Orthopedic, Dental & Dermal Implants), By Players/Companies NuVasive, Maxigen Biotech Inc, Edwards LifeSciences Corporation, Acelity, Inc, CryoLife, Osiris Therapeutics These players are involved in the implementation of portfolio separations and regional expansion strategies as a value-enhancement opportunity for enhancing the market presence, Biotissue Technologies, RTI Surgical, Inc, IOP Ophthalmics, Vericel, Stryker Corporation, Baxter International, Organogenesis Inc, Integra LifeSciences Corporation, Aplhatec Spine Inc, Conmed Corporation Allergan Plc, BioPolymer GmbH & Co KG, Medtronic, MiMedx Group, Auto Tissue Berlin GmbH”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Biological Implants Market Report Segments:

The market is segmented by Product (Xenografts, Autografts, Allografts), by Application (Cardiovascular Orthopedic, Dental & Dermal Implants).

Biological Implants Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Biological Implants Market

Overview of the regional outlook of the Biological Implants Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Biological Implants Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Biological Implants Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Xenografts

                2. Autografts

                3. Allografts

                1. Cardiovascular Orthopedic

                2. Dental & Dermal Implants

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biological Implants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Biological Implants Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.